UK markets closed
NIKKEI 225
27,001.52 +262.49 (+0.98%) HANG SENG
20,470.06 -247.18 (-1.19%) CRUDE OIL
110.37 +0.09 (+0.08%) GOLD FUTURES
1,852.60 +10.50 (+0.57%) DOW
31,840.97 +579.07 (+1.85%) BTC-GBP
23,253.19 -698.79 (-2.92%)
Beam Therapeutics Inc. (BEAM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
| Previous close | 35.19 |
| Open | 35.14 |
| Bid | 34.97 x 800 |
| Ask | 35.05 x 900 |
| Day's range | 34.61 - 37.14 |
| 52-week range | 27.77 - 138.52 |
| Volume | |
| Avg. volume | 1,209,616 |
| Market cap | 2.462B |
| Beta (5Y monthly) | 1.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.59 |
| Earnings date | 08 Aug 2022 - 12 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 99.20 |
- Simply Wall St.
Newsflash: Beam Therapeutics Inc. (NASDAQ:BEAM) Analysts Have Been Trimming Their Revenue Forecasts
One thing we could say about the analysts on Beam Therapeutics Inc. ( NASDAQ:BEAM ) - they aren't optimistic, having...
- Zacks
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 8.18% and 89.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Aeglea Biotherapeutics (AGLE) Reports Q1 Loss, Lags Revenue Estimates
Aeglea (AGLE) delivered earnings and revenue surprises of -5.71% and 6.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
